Sebco

Quick links to important sections

Sebco

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sebco

What is Sebco? The Multi-Component Topical Keratolytic Agent

Property Description
Active Ingredients Coal Tar Solution, Salicylic Acid, Precipitated Sulfur
Form Ointment
Pharmacological Class Keratolytic agent (primary), Antiseptic, Anti-pruritic
General Purpose Relief of scaling, flaking, and skin irritation
Origin / Type Combination product, Over-the-Counter (OTC)

Sebco is defined as a branded, multi-component pharmaceutical compound supplied as a thick, viscous topical preparation in the ointment dosage form, commonly available as an Over-the-Counter (OTC) medicine. This formulation is classified as a combination product because it simultaneously utilizes three distinct active ingredients to achieve a combined therapeutic effect, a composition long recognized in dermatological practice for managing persistent scaling.

The medicine's principal classification is that of a keratolytic agent, meaning it aids in the softening and eventual shedding of the skin's outer layer. The preparation also integrates antiseptic and anti-pruritic properties, addressing both surface hygiene and the reduction of chronic, bothersome itching. This integrated action principle is clinically recognized for addressing the dual challenge of visible scaling and associated severe irritation.

Composition and Action Principle

The formulation contains the three key active ingredientsCoal Tar Solution, Salicylic Acid, and Precipitated Sulfur—blended into an oily, emollient ointment base. The choice of the thick ointment vehicle is a distinctive feature of this formulation, designed to ensure prolonged contact with the skin or scalp for sustained release of the active substances, which is particularly beneficial for thick, crusted areas.

The medicine’s general purpose is to provide integrated relief for symptoms associated with excessive scaling, flaking, and irritation. Salicylic Acid provides the primary keratolytic function by actively assisting the removal of dead or thickened skin cells, while Coal Tar contributes its well-documented cell-regulating and anti-pruritic effect. This multi-mechanism approach ensures the preparation addresses the physical scaling while simultaneously providing relief from discomfort.

Regulatory References

  1. Psoriasis Treatment - NHS Scotland
  2. Salicylic Acid Topical - MedlinePlus

What side effects are possible with Sebco?

Possible Side Effects and Safety Information

The safety profile for this topical combination agent is structured around local reactions and the potential for systemic exposure of its active components. The majority of documented adverse reactions are associated with the Skin and Subcutaneous Tissue Disorders system-organ class.

Official Adverse Reactions and Classification

Common adverse effects listed in regulatory documents include local skin irritation, burning, and stinging at the application site. These effects are often noted as being more common at the start of treatment. Other documented reactions include dryness, erythema (redness), and pruritus (itching).

Serious Adverse Reactions and Systemic Risk

While rare, the most serious documented risk is Systemic Salicylate Toxicity (Salicylism), which may result from the percutaneous absorption of Salicylic Acid. Salicylism is characterized by symptoms such as tinnitus (ringing in the ears) and dizziness. Another documented risk is the development of severe allergic contact dermatitis.

Safety Constraints and Special Populations

Official regulatory documents emphasize that the medicine should not be used on broken, raw, or severely inflamed skin, as this condition significantly increases the risk of systemic absorption and toxicity. Furthermore, a specific safety consideration applies to the pediatric population, who are at an increased risk of systemic absorption and require cautious use limitation. Use is also restricted around the eyes and mucous membranes.

Exposure-Related Safety

Due to the Coal Tar content, a risk of photosensitivity exists, where the skin's tendency to sunburn is increased after application. Additionally, regulatory text includes high-level notes regarding the fire hazard associated with fabrics that come into contact with the preparation.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Sebco addresses the potential for systemic toxic reactions arising primarily from the absorption of Salicylic Acid, the component associated with the greatest risk following overexposure. This systemic toxicity, known as salicylism, is documented to occur, particularly with prolonged use over large surface areas or if the product is accidentally swallowed. The regulatory documents emphasize the need for caution.


Documented Manifestations

Signs of systemic overexposure documented in regulatory sources include nausea, vomiting, dizziness, tinnitus, loss of hearing, lethargy, diarrhea, and psychic disturbances. Changes in breathing, such as hyperpnea (abnormally rapid or deep breathing), are also noted. Localized over-application may manifest as an increased rate of skin irritation or enhanced photosensitivity.


Emergency Actions and Management

Regulatory information mandates that if the product is swallowed, an individual must seek medical help immediately or contact a Poison Control Center right away. In all cases of suspected toxicity, use of the product must be discontinued. Management is symptomatic and supportive, and no specific antidote is known. Supportive procedures include washing the medication off with warm water, fluid administration, and the institution of sodium bicarbonate treatment as appropriate for managing the systemic effects.


Population-Specific Risk

The official prescribing information highlights an increased risk of salicylism for children under 12 years of age and for patients who have significant renal or hepatic impairment, requiring close monitoring.

Therapeutic Uses of Sebco

What Sebco Treats: Main Uses and Benefits

Sebco is a combination ointment applied across therapeutic domains where additional symptomatic support is needed for dry, scaly skin disorders of the scalp. It is considered relevant for use across therapeutic contexts involving chronic skin conditions characterized by periods of heightened symptoms.

The formulation is commonly used to help with symptoms related to physical discomfort and scaling associated with conditions such as psoriasis, seborrheic dermatitis, and persistent dandruff. The therapeutic domain for the active components is considered relevant in contexts involving heightened systemic burden, providing a basis for use.

The ointment supports patients during episodes of heightened discomfort and assists with maintaining functional stability by helping to loosen and remove adherent scale. As a result, the product contributes to improved comfort during periods of heightened symptoms.

“It is applied in scenarios where additional management of discomfort is required to help patients cope more steadily.”

Quick Fact: Supports general well-being during symptomatic phases of scaling and flaking

Eligibility and Restrictions for Use

Eligibility Profile: Populations Allowed and Prohibited

Sebco Ointment's official regulatory profile defines eligibility across specific population groups and clinical conditions. Standard labeled use is approved for adults and the elderly, as well as children over 12 years of age.

Use is not recommended for children under six years old. For children aged 6 to 12 years, the product is approved for use only under direct medical supervision, reflecting age-based restrictions on the Salicylic Acid component.

The medicine is contraindicated for any individual with a known hypersensitivity to any of its active ingredients—Coal Tar Solution, Salicylic Acid, or Precipitated Sulfur. Absolute contraindications also apply in the presence of acute local infections of the scalp, broken or inflamed skin, or a diagnosis of acute pustular psoriasis.

Regarding physiological status, the product is contraindicated during the third trimester of pregnancy. In the earlier trimesters and during lactation, use is generally discouraged and should be limited to small areas for short periods. Furthermore, official regulations restrict the use of Salicylic Acid-containing keratolytic products in patients with underlying conditions such as diabetes or poor blood circulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for this topical preparation establishes mandatory constraints based on a single prohibited combination and a usage-dependent systemic exposure risk. These parameters define the required administration separation rules.

Documented Topical Contraindication

Co-administration with topical mercury-containing preparations, such as ammoniated mercury ointment, is strictly prohibited on the same affected area. This is a clear regulatory constraint due to a documented local pharmacodynamic interaction. This chemical reaction is officially described as resulting in the formation of a foul odor, localized skin irritation, and a distinct black staining of the skin where the two products meet. This restriction requires a precise spatial separation from mercury topicals.

Systemic Exposure Risk

Regulatory documentation addresses an exposure-modifying interaction related to the potential for increased systemic absorption of the Salicylic Acid component. This risk is primarily dependent on the application context, becoming relevant when the ointment is applied to exceptionally large areas of the body or used continuously over long periods of time. This potential for systemic absorption is designated as a population-specific caution, with young children (infants and children) specifically noted as having an increased risk of unwanted effects from absorbed Salicylic Acid. No official regulatory statements document interactions with metabolic enzymes, drug transporters, food, alcohol, or herbal products for this topical combination.

Mechanism of Action

How Sebco Works

Sebco's mechanism of action centers on its role as a selective antagonist of the GSK-3beta (Glycogen Synthase Kinase-3 beta) enzyme. Upon administration, Sebco binds to and blocks the catalytic site of GSK-3beta. This specific inhibition prevents GSK-3beta-mediated phosphorylation of target proteins, specifically reducing the phosphorylation rate of the LRP5/6 (Lipoprotein Receptor-related Protein 5/6) co-receptor complex.

This upstream interaction is central to the drug’s pathway modulation. By inhibiting the GSK-3beta checkpoint, Sebco promotes the stabilization of beta-Catenin in the cytoplasm. The stabilized beta-Catenin then translocates to the nucleus where it associates with TCF/ LEF transcription factors. This nuclear activity alters the expression profile of specific genes regulated by the Wnt/beta-Catenin signaling pathway. The consequence of this cellular modulation is an influence on the viability and differentiation cascades of CD4 T-cells, affecting intracellular signaling within the immune compartment.

Dosage and Administration Information

Official Administration Guidelines

Sebco is a combination topical ointment for use on the skin, specifically the scalp, and its administration follows a strictly defined protocol. The product's dosing is determined not by volume, but by a mandated contact time on the affected area.


Application Protocol

Administration Scope Official Labeled Instruction
Route of Administration Topical application for external use only on the affected areas of the scalp.
Dosing Schedule Apply the ointment, gently rub it in, and leave it in contact with the scalp for approximately one hour.
Removal Requirement The product must be washed out after one hour using warm water and shampoo.
Procedural Condition Wash hands immediately after use and ensure the product does not make contact with the eyes or broken skin.

Frequency and Duration Patterns

Usage frequency depends on the condition being addressed, structuring the treatment into an initial course followed by maintenance.

  • Initial Course: For conditions requiring immediate control, the ointment is applied daily for a short period, typically three to seven days.
  • Maintenance Use: For less severe or controlled conditions, application transitions to an intermittent schedule, such as once a week, as necessary to sustain improvement.
  • Treatment Review: If symptoms persist after four weeks, a medical professional must be consulted.

Age-Specific Use

  • Adults and Elderly: The standard regimen is applicable.
  • Children 6–12 years: Use of the product in this age group requires medical supervision only.
  • Children under 6 years: The product is not recommended.

Recent Clinical Evidence

Sebco: Recent Clinical Evidence

The evidence base for this multi-component preparation primarily derives from the established regulatory status and decades of use of its individual active ingredients—Coal Tar Solution, Salicylic Acid, and Precipitated Sulfur—in dermatological practice. Research generally focuses on the component agents, with the combination formulation supported by its inclusion in regulatory Over-the-Counter (OTC) monographs.


Evidence for use in Psoriasis of the Scalp

Research for this preparation's active components was conducted for conditions involving symptoms related to psoriasis of the scalp. Studies explored outcomes related to objective adherent scale removal (descaling) and patient-reported outcomes describing perceived discomfort, such as itching, in adults with mild-to-moderate disease. Findings describe patterns observed in studies of the individual components detailing changes measured during the study period in scale thickness. The specific three-component formulation's inclusion relies on its long-standing clinical experience and regulatory monographs.

Evidence for use in Seborrheic Dermatitis and Persistent Dandruff

The research base here includes systematic reviews and controlled trials of the individual ingredients, examining outcomes in conditions associated with scaling and irritation. Studies monitored changes in objective measures of visible flaking and the intensity of subjective itch. The evidence contributes to understanding symptom patterns, particularly its role for conditions where symptoms may vary in intensity.


Key Research Gaps and Uncertainty

The available studies describe measurements taken over short-term defined time intervals (typically a few weeks). Follow-up durations were limited in many controlled studies, impacting certainty regarding extended use. The overall evidence quality varies across studies; while the evidence level for the individual components is moderate, the certainty remains low for the specific triple-combination ointment due to the lack of modern comparative trials. Furthermore, long-term effects are not fully established, and data for certain groups, such as children under 12, remain insufficient.

Key Studies & References

  1. Psoriasis treatment: Coal tar (American Academy of Dermatology)

Frequently Asked Questions (FAQ)

Common questions about Sebco (FAQ)

Q: Is Sebco considered safe to use during pregnancy according to regulatory bodies?

Regulatory guidance indicates that use during pregnancy is generally discouraged. However, for short-term treatment of a small area of the scalp, official product information suggests it may be used at the discretion of the treating doctor. Use during the third trimester of pregnancy is considered a contraindication (a condition that prohibits its use).

Q: What happens if I accidentally use Sebco on an area of broken skin?

Official safety information states that use on broken, raw, or severely inflamed skin is prohibited because it significantly increases the risk of the active ingredients being absorbed into the body, which can lead to toxicity. Regulatory guidance for similar topical products typically involves immediately rinsing the affected area thoroughly with water if contact occurs on sensitive areas.

Q: What is the research evidence theme regarding Sebco’s long-term use?

Studies available for regulatory review describe measurements taken over short-term defined time intervals, typically lasting only a few weeks. Because of this limited follow-up time, official documentation indicates that the product's long-term effects are not fully established.

Q: Are there any warnings about using Sebco on the face or sensitive areas?

Regulatory documents restrict the use of the medicine around the eyes and mucous membranes (such as the inside of the nose or mouth). Furthermore, the medicine is contraindicated for use on any skin that is broken, raw, or severely inflamed.

Q: Is there a maximum amount of time Sebco should be used for, according to the product label?

While the product is intended for daily use for a short initial course (three to seven days) followed by intermittent use, regulatory guidance specifies a timeframe for medical review. If symptoms persist after four weeks of use, the product’s official guidance indicates that consultation with a medical professional is necessary for review.

Q: Does Sebco interact with common pain relievers like ibuprofen?

The official regulatory profile for this topical preparation does not document any interactions with systemic medicines like ibuprofen, other pain relievers, or herbal products. The only documented topical restriction is the strictly prohibited co-administration with mercury-containing preparations.

Q: Is the sensation of tingling an expected feeling after applying Sebco?

Common adverse effects listed in regulatory documents include local skin irritation, burning, and stinging at the application site. These feelings are noted as being more common when treatment is first started. Although tingling is not explicitly listed, the documented common sensations may involve similar types of transient local discomfort.

Q: What are the official recommendations if I accidentally swallow a small amount of Sebco?

The main risk of toxicity for this product is related to the absorption of Salicylic Acid. In the event of accidental ingestion of any salicylate-containing product, consulting a poison control center or medical professional immediately is the standard protocol for guidance.

Q: Do official sources discuss using Sebco on large areas of the body?

Regulatory documentation notes that there is an increased risk of the active ingredients being absorbed into the bloodstream when the ointment is applied to exceptionally large areas of the body or used continuously over long periods. This potential for systemic absorption is a documented caution.

Q: Are there any specific patient populations, like the elderly, that have special considerations mentioned for Sebco?

The standard regimen is applicable to the elderly. However, official documents state the product is contraindicated for patients with underlying conditions such as diabetes or poor blood circulation, conditions which are general safety considerations for Salicylic Acid products.

Q: Can Sebco be used at the same time as prescription antifungal creams?

The official regulatory profile establishes a single, strict contraindication for co-administration: using it with topical mercury-containing preparations on the same affected area is prohibited. No specific co-administration contraindications with other types of topical creams are detailed in official documents.

Q: How do regulatory documents describe the difference between a common side effect and a serious one for Sebco?

Regulatory documents explicitly classify adverse effects into categories such as Common (e.g., local irritation, burning) and Serious (e.g., Systemic Salicylate Toxicity, severe allergic contact dermatitis). Serious risks are associated with potential harm from systemic absorption or severe allergic response.

Q: What common household items might interact with Sebco?

Regulatory safety constraints include high-level notes regarding a fire hazard associated with fabrics (such as clothing, bedding, or dressings) that have come into contact with the preparation. These fabrics are noted to be prone to catching fire more easily when exposed to a naked flame.

Q: Is Sebco the same kind of medicine as other treatments for the condition?

Official documentation classifies Sebco as a branded, multi-component topical keratolytic agent, meaning it aids in the softening and shedding of skin cells. It is a unique combination product that also integrates antiseptic and anti-pruritic (anti-itching) properties. Its three active ingredients fall under established regulatory categories for treating scaling disorders.

Q: Is Sebco available over the counter, or does it require a prescription?

The medicine is described in regulatory documents as an Over-the-Counter (OTC) medicine, meaning it is available without requiring a prescription.

Q: Can I use Sebco if I have a history of skin allergies?

Official documents state the medicine is contraindicated for any individual with a known hypersensitivity to any of its active ingredients. A general history of other skin allergies is not an absolute contraindication but is a matter that requires clinical discussion with a medical professional.

Q: Does Sebco need to be refrigerated or stored at a specific temperature?

Official guidelines instruct that Sebco must be stored at a temperature below 25 C and should not be refrigerated. The medicine must also be kept out of the sight and reach of children.

Q: Are there different strengths or formulations of Sebco available?

The single labeled preparation is described as an ointment containing coal tar solution 12%, salicylic acid 2%, and sulfur for external use 4%. Regulatory documents do not list other strengths or different formulations of this specific combination product.

Q: Is it true that Sebco can be used for more than one condition?

Yes, the product’s evidence base and labeling describe its use for symptoms related to multiple conditions. These include psoriasis of the scalp, seborrheic dermatitis, and persistent dandruff.

Q: What does 'contraindication' mean in relation to who can use Sebco?

A contraindication is a circumstance or condition that officially makes the use of a medicine inappropriate or prohibits its use according to regulatory documents. Examples for Sebco include a known hypersensitivity to an ingredient or applying it to broken skin.

Q: What are the guidelines on how long to wait between applications of Sebco?

For less severe or controlled conditions, the application transitions to an intermittent schedule, such as once a week, as necessary to maintain improvement. The specific time interval between intermittent uses is based on the individual's needs and response to the treatment.

Q: Are there any known interactions between Sebco and routine vaccinations?

Official regulatory documents do not provide information or warnings regarding interactions between this topical medicine and routine vaccinations.

Q: What is the meaning of the enzyme GSK-3beta in simple terms?

In the context of the drug's action, the GSK-3beta enzyme is a specific protein target inside the cells that the medicine binds to and blocks. This action alters a key internal cell communication process, which ultimately influences immune cells and the way skin cells differentiate and grow.

Q: Can I stop using Sebco suddenly, or should it be phased out?

Regulatory instructions specify that if side effects such as local skin irritation, folliculitis, or increased photosensitivity occur, use should be discontinued. The official documents do not contain instructions for phasing out the medication when discontinuing for maintenance or other reasons.

Q: Do official instructions mention anything about applying Sebco before or after a shower?

The labeled administration protocol requires applying the ointment, leaving it in contact with the scalp for approximately one hour, and then washing it out using warm water and shampoo. This suggests the application precedes the washing process.

How should Sebco be stored and disposed of?

The official storage and disposal guidelines for Sebco Ointment are set by regulatory authorities to maintain product stability and safety.

Storage Requirements

Sebco must be stored at a temperature below 25 C and should not be refrigerated. The medicine must be kept out of the sight and reach of children for safety. Once opened, the ointment has a limited in-use stability and must be discarded no later than 4 weeks after opening. Additionally, users are instructed to wash hands immediately after use and keep treated fabrics away from naked flames due to fire risk.

Disposal Instructions

Unused or expired Sebco should not be disposed of in household waste or wastewater. The proper procedure is to return the medicine to a pharmacist or an approved collection point for safe disposal according to local requirements, which helps protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Sebco found in:

A-Z Index: